Aspen Pharmacare Holdings Ltd. | Cash Flow
Fiscal year is July-June. All values ZAR Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,049
7,425
8,450
9,000
8,300
9,237
Depreciation, Depletion & Amortization
550
824
1,039
1,200
1,300
1,372
Other Funds
1
-
5
-
-
2,013
Funds from Operations
4,576
6,024
6,306
6,600
7,400
8,596
Changes in Working Capital
590
2,188
1,467
3,400
900
1,579
Net Operating Cash Flow
3,986
3,836
4,839
3,200
6,500
7,017
Capital Expenditures
4,322
2,029
2,417
2,800
2,900
Sale of Fixed Assets & Businesses
11
130
185
5,200
100
Purchase/Sale of Investments
-
-
116
-
-
Net Investing Cash Flow
6,283
20,850
1,561
1,100
11,700
Cash Dividends Paid - Total
715
716
858
1,000
1,200
Issuance/Reduction of Debt, Net
4,336
19,645
1,623
2,000
6,700
Net Financing Cash Flow
3,611
18,909
2,499
3,100
5,500
Net Change in Cash
1,426
2,207
440
1,000
200
Free Cash Flow
3,319
2,507
3,246
1,500
5,000
Net Assets from Acquisitions
1,579
19,764
2,652
700
9,500
Other Sources
4
899
3,463
200
800
Change in Capital Stock
12
20
23
100
-
Exchange Rate Effect
113
312
339
200
500
Other Uses
397
86
23
800
200
About Aspen Pharmacare Holdings
View Profile
